COVID-19 Impact on Automation in Biopharmaceutical Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Automation in Biopharmaceutical, including the following market information:
Major competitors identified in this market include Danaher, GE, PerkinElmer, Tecan Trading, Thermo Fisher Scientific, Bruker, Peak Analysis and Automation, Waters, Capsugel, RheoSense, Eirechrom, BioProcess International, Novasep, etc.
Based on the Region:
- Global Automation in Biopharmaceutical Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Automation in Biopharmaceutical Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Automation in Biopharmaceutical Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Automation in Biopharmaceutical Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Danaher, GE, PerkinElmer, Tecan Trading, Thermo Fisher Scientific, Bruker, Peak Analysis and Automation, Waters, Capsugel, RheoSense, Eirechrom, BioProcess International, Novasep, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Clinical Stage Automation
- Drug Discovery Stage Automation
- Research and Development
- Clinical
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Automation in Biopharmaceutical Industry
1.7 COVID-19 Impact: Automation in Biopharmaceutical Market Trends
2 GLOBAL AUTOMATION IN BIOPHARMACEUTICAL QUARTERLY MARKET SIZE ANALYSIS
2.1 Automation in Biopharmaceutical Business Impact Assessment - COVID-19
2.1.1 Global Automation in Biopharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Automation in Biopharmaceutical Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Automation in Biopharmaceutical Quarterly Market Size, 2019 VS 2020
3.2 By Players, Automation in Biopharmaceutical Headquarters and Area Served
3.3 Date of Key Players Enter into Automation in Biopharmaceutical Market
3.4 Key Players Automation in Biopharmaceutical Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON AUTOMATION IN BIOPHARMACEUTICAL SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Clinical Stage Automation
1.4.2 Drug Discovery Stage Automation
4.2 By Type, Global Automation in Biopharmaceutical Market Size, 2019-2021
5 IMPACT OF COVID-19 ON AUTOMATION IN BIOPHARMACEUTICAL SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Research and Development
5.5.2 Clinical
5.2 By Application, Global Automation in Biopharmaceutical Market Size, 2019-2021
5.2.1 By Application, Global Automation in Biopharmaceutical Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Danaher
7.1.1 Danaher Business Overview
7.1.2 Danaher Automation in Biopharmaceutical Quarterly Revenue, 2020
7.1.3 Danaher Automation in Biopharmaceutical Product Introduction
7.1.4 Danaher Response to COVID-19 and Related Developments
7.2 GE
7.2.1 GE Business Overview
7.2.2 GE Automation in Biopharmaceutical Quarterly Revenue, 2020
7.2.3 GE Automation in Biopharmaceutical Product Introduction
7.2.4 GE Response to COVID-19 and Related Developments
7.3 PerkinElmer
7.3.1 PerkinElmer Business Overview
7.3.2 PerkinElmer Automation in Biopharmaceutical Quarterly Revenue, 2020
7.3.3 PerkinElmer Automation in Biopharmaceutical Product Introduction
7.3.4 PerkinElmer Response to COVID-19 and Related Developments
7.4 Tecan Trading
7.4.1 Tecan Trading Business Overview
7.4.2 Tecan Trading Automation in Biopharmaceutical Quarterly Revenue, 2020
7.4.3 Tecan Trading Automation in Biopharmaceutical Product Introduction
7.4.4 Tecan Trading Response to COVID-19 and Related Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Business Overview
7.5.2 Thermo Fisher Scientific Automation in Biopharmaceutical Quarterly Revenue, 2020
7.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Product Introduction
7.5.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.6 Bruker
7.6.1 Bruker Business Overview
7.6.2 Bruker Automation in Biopharmaceutical Quarterly Revenue, 2020
7.6.3 Bruker Automation in Biopharmaceutical Product Introduction
7.6.4 Bruker Response to COVID-19 and Related Developments
7.7 Peak Analysis and Automation
7.7.1 Peak Analysis and Automation Business Overview
7.7.2 Peak Analysis and Automation Automation in Biopharmaceutical Quarterly Revenue, 2020
7.7.3 Peak Analysis and Automation Automation in Biopharmaceutical Product Introduction
7.7.4 Peak Analysis and Automation Response to COVID-19 and Related Developments
7.8 Waters
7.8.1 Waters Business Overview
7.8.2 Waters Automation in Biopharmaceutical Quarterly Revenue, 2020
7.8.3 Waters Automation in Biopharmaceutical Product Introduction
7.8.4 Waters Response to COVID-19 and Related Developments
7.9 Capsugel
7.9.1 Capsugel Business Overview
7.9.2 Capsugel Automation in Biopharmaceutical Quarterly Revenue, 2020
7.9.3 Capsugel Automation in Biopharmaceutical Product Introduction
7.9.4 Capsugel Response to COVID-19 and Related Developments
7.10 RheoSense
7.10.1 RheoSense Business Overview
7.10.2 RheoSense Automation in Biopharmaceutical Quarterly Revenue, 2020
7.10.3 RheoSense Automation in Biopharmaceutical Product Introduction
7.10.4 RheoSense Response to COVID-19 and Related Developments
7.11 Eirechrom
7.11.1 Eirechrom Business Overview
7.11.2 Eirechrom Automation in Biopharmaceutical Quarterly Revenue, 2020
7.11.3 Eirechrom Automation in Biopharmaceutical Product Introduction
7.11.4 Eirechrom Response to COVID-19 and Related Developments
7.12 BioProcess International
7.12.1 BioProcess International Business Overview
7.12.2 BioProcess International Automation in Biopharmaceutical Quarterly Revenue, 2020
7.12.3 BioProcess International Automation in Biopharmaceutical Product Introduction
7.12.4 BioProcess International Response to COVID-19 and Related Developments
7.13 Novasep
7.13.1 Novasep Business Overview
7.13.2 Novasep Automation in Biopharmaceutical Quarterly Revenue, 2020
7.13.3 Novasep Automation in Biopharmaceutical Product Introduction
7.13.4 Novasep Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Automation in Biopharmaceutical Industry
1.7 COVID-19 Impact: Automation in Biopharmaceutical Market Trends
2 GLOBAL AUTOMATION IN BIOPHARMACEUTICAL QUARTERLY MARKET SIZE ANALYSIS
2.1 Automation in Biopharmaceutical Business Impact Assessment - COVID-19
2.1.1 Global Automation in Biopharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Automation in Biopharmaceutical Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Automation in Biopharmaceutical Quarterly Market Size, 2019 VS 2020
3.2 By Players, Automation in Biopharmaceutical Headquarters and Area Served
3.3 Date of Key Players Enter into Automation in Biopharmaceutical Market
3.4 Key Players Automation in Biopharmaceutical Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON AUTOMATION IN BIOPHARMACEUTICAL SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Clinical Stage Automation
1.4.2 Drug Discovery Stage Automation
4.2 By Type, Global Automation in Biopharmaceutical Market Size, 2019-2021
5 IMPACT OF COVID-19 ON AUTOMATION IN BIOPHARMACEUTICAL SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Research and Development
5.5.2 Clinical
5.2 By Application, Global Automation in Biopharmaceutical Market Size, 2019-2021
5.2.1 By Application, Global Automation in Biopharmaceutical Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Danaher
7.1.1 Danaher Business Overview
7.1.2 Danaher Automation in Biopharmaceutical Quarterly Revenue, 2020
7.1.3 Danaher Automation in Biopharmaceutical Product Introduction
7.1.4 Danaher Response to COVID-19 and Related Developments
7.2 GE
7.2.1 GE Business Overview
7.2.2 GE Automation in Biopharmaceutical Quarterly Revenue, 2020
7.2.3 GE Automation in Biopharmaceutical Product Introduction
7.2.4 GE Response to COVID-19 and Related Developments
7.3 PerkinElmer
7.3.1 PerkinElmer Business Overview
7.3.2 PerkinElmer Automation in Biopharmaceutical Quarterly Revenue, 2020
7.3.3 PerkinElmer Automation in Biopharmaceutical Product Introduction
7.3.4 PerkinElmer Response to COVID-19 and Related Developments
7.4 Tecan Trading
7.4.1 Tecan Trading Business Overview
7.4.2 Tecan Trading Automation in Biopharmaceutical Quarterly Revenue, 2020
7.4.3 Tecan Trading Automation in Biopharmaceutical Product Introduction
7.4.4 Tecan Trading Response to COVID-19 and Related Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Business Overview
7.5.2 Thermo Fisher Scientific Automation in Biopharmaceutical Quarterly Revenue, 2020
7.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Product Introduction
7.5.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.6 Bruker
7.6.1 Bruker Business Overview
7.6.2 Bruker Automation in Biopharmaceutical Quarterly Revenue, 2020
7.6.3 Bruker Automation in Biopharmaceutical Product Introduction
7.6.4 Bruker Response to COVID-19 and Related Developments
7.7 Peak Analysis and Automation
7.7.1 Peak Analysis and Automation Business Overview
7.7.2 Peak Analysis and Automation Automation in Biopharmaceutical Quarterly Revenue, 2020
7.7.3 Peak Analysis and Automation Automation in Biopharmaceutical Product Introduction
7.7.4 Peak Analysis and Automation Response to COVID-19 and Related Developments
7.8 Waters
7.8.1 Waters Business Overview
7.8.2 Waters Automation in Biopharmaceutical Quarterly Revenue, 2020
7.8.3 Waters Automation in Biopharmaceutical Product Introduction
7.8.4 Waters Response to COVID-19 and Related Developments
7.9 Capsugel
7.9.1 Capsugel Business Overview
7.9.2 Capsugel Automation in Biopharmaceutical Quarterly Revenue, 2020
7.9.3 Capsugel Automation in Biopharmaceutical Product Introduction
7.9.4 Capsugel Response to COVID-19 and Related Developments
7.10 RheoSense
7.10.1 RheoSense Business Overview
7.10.2 RheoSense Automation in Biopharmaceutical Quarterly Revenue, 2020
7.10.3 RheoSense Automation in Biopharmaceutical Product Introduction
7.10.4 RheoSense Response to COVID-19 and Related Developments
7.11 Eirechrom
7.11.1 Eirechrom Business Overview
7.11.2 Eirechrom Automation in Biopharmaceutical Quarterly Revenue, 2020
7.11.3 Eirechrom Automation in Biopharmaceutical Product Introduction
7.11.4 Eirechrom Response to COVID-19 and Related Developments
7.12 BioProcess International
7.12.1 BioProcess International Business Overview
7.12.2 BioProcess International Automation in Biopharmaceutical Quarterly Revenue, 2020
7.12.3 BioProcess International Automation in Biopharmaceutical Product Introduction
7.12.4 BioProcess International Response to COVID-19 and Related Developments
7.13 Novasep
7.13.1 Novasep Business Overview
7.13.2 Novasep Automation in Biopharmaceutical Quarterly Revenue, 2020
7.13.3 Novasep Automation in Biopharmaceutical Product Introduction
7.13.4 Novasep Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Automation in Biopharmaceutical Assessment
Table 9. COVID-19 Impact: Automation in Biopharmaceutical Market Trends
Table 10. COVID-19 Impact Global Automation in Biopharmaceutical Market Size
Table 11. Global Automation in Biopharmaceutical Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Automation in Biopharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Automation in Biopharmaceutical Market Growth Drivers
Table 14. Global Automation in Biopharmaceutical Market Restraints
Table 15. Global Automation in Biopharmaceutical Market Opportunities
Table 16. Global Automation in Biopharmaceutical Market Challenges
Table 17. By Players, Automation in Biopharmaceutical Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Automation in Biopharmaceutical Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Automation in Biopharmaceutical Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Automation in Biopharmaceutical Market
Table 21. Key Players Automation in Biopharmaceutical Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Automation in Biopharmaceutical Market Size 2019-2021, (US$ Million)
Table 24. Global Automation in Biopharmaceutical Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Automation in Biopharmaceutical Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 57. Danaher Business Overview
Table 58. Danaher Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Danaher Automation in Biopharmaceutical Product
Table 60. Danaher Response to COVID-19 and Related Developments
Table 61. GE Business Overview
Table 62. GE Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. GE Automation in Biopharmaceutical Product
Table 64. GE Response to COVID-19 and Related Developments
Table 65. PerkinElmer Business Overview
Table 66. PerkinElmer Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. PerkinElmer Automation in Biopharmaceutical Product
Table 68. PerkinElmer Response to COVID-19 and Related Developments
Table 69. Tecan Trading Business Overview
Table 70. Tecan Trading Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Tecan Trading Automation in Biopharmaceutical Product
Table 72. Tecan Trading Response to COVID-19 and Related Developments
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Thermo Fisher Scientific Automation in Biopharmaceutical Product
Table 76. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 77. Bruker Business Overview
Table 78. Bruker Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Bruker Automation in Biopharmaceutical Product
Table 80. Bruker Response to COVID-19 and Related Developments
Table 81. Peak Analysis and Automation Business Overview
Table 82. Peak Analysis and Automation Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Peak Analysis and Automation Automation in Biopharmaceutical Product
Table 84. Peak Analysis and Automation Response to COVID-19 and Related Developments
Table 85. Waters Business Overview
Table 86. Waters Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Waters Automation in Biopharmaceutical Product
Table 88. Waters Response to COVID-19 and Related Developments
Table 89. Capsugel Business Overview
Table 90. Capsugel Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Capsugel Automation in Biopharmaceutical Product
Table 92. Capsugel Response to COVID-19 and Related Developments
Table 93. RheoSense Business Overview
Table 94. RheoSense Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. RheoSense Automation in Biopharmaceutical Product
Table 96. RheoSense Response to COVID-19 and Related Developments
Table 97. Eirechrom Business Overview
Table 98. Eirechrom Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Eirechrom Automation in Biopharmaceutical Product
Table 100. Eirechrom Response to COVID-19 and Related Developments
Table 101. BioProcess International Business Overview
Table 102. BioProcess International Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. BioProcess International Automation in Biopharmaceutical Product
Table 104. BioProcess International Response to COVID-19 and Related Developments
Table 105. Novasep Business Overview
Table 106. Novasep Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Novasep Automation in Biopharmaceutical Product
Table 108. Novasep Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Automation in Biopharmaceutical Assessment
Table 9. COVID-19 Impact: Automation in Biopharmaceutical Market Trends
Table 10. COVID-19 Impact Global Automation in Biopharmaceutical Market Size
Table 11. Global Automation in Biopharmaceutical Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Automation in Biopharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Automation in Biopharmaceutical Market Growth Drivers
Table 14. Global Automation in Biopharmaceutical Market Restraints
Table 15. Global Automation in Biopharmaceutical Market Opportunities
Table 16. Global Automation in Biopharmaceutical Market Challenges
Table 17. By Players, Automation in Biopharmaceutical Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Automation in Biopharmaceutical Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Automation in Biopharmaceutical Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Automation in Biopharmaceutical Market
Table 21. Key Players Automation in Biopharmaceutical Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Automation in Biopharmaceutical Market Size 2019-2021, (US$ Million)
Table 24. Global Automation in Biopharmaceutical Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Automation in Biopharmaceutical Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Automation in Biopharmaceutical Market Size, 2019-2021 (US$ Million)
Table 57. Danaher Business Overview
Table 58. Danaher Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Danaher Automation in Biopharmaceutical Product
Table 60. Danaher Response to COVID-19 and Related Developments
Table 61. GE Business Overview
Table 62. GE Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. GE Automation in Biopharmaceutical Product
Table 64. GE Response to COVID-19 and Related Developments
Table 65. PerkinElmer Business Overview
Table 66. PerkinElmer Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. PerkinElmer Automation in Biopharmaceutical Product
Table 68. PerkinElmer Response to COVID-19 and Related Developments
Table 69. Tecan Trading Business Overview
Table 70. Tecan Trading Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Tecan Trading Automation in Biopharmaceutical Product
Table 72. Tecan Trading Response to COVID-19 and Related Developments
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Thermo Fisher Scientific Automation in Biopharmaceutical Product
Table 76. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 77. Bruker Business Overview
Table 78. Bruker Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Bruker Automation in Biopharmaceutical Product
Table 80. Bruker Response to COVID-19 and Related Developments
Table 81. Peak Analysis and Automation Business Overview
Table 82. Peak Analysis and Automation Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Peak Analysis and Automation Automation in Biopharmaceutical Product
Table 84. Peak Analysis and Automation Response to COVID-19 and Related Developments
Table 85. Waters Business Overview
Table 86. Waters Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Waters Automation in Biopharmaceutical Product
Table 88. Waters Response to COVID-19 and Related Developments
Table 89. Capsugel Business Overview
Table 90. Capsugel Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Capsugel Automation in Biopharmaceutical Product
Table 92. Capsugel Response to COVID-19 and Related Developments
Table 93. RheoSense Business Overview
Table 94. RheoSense Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. RheoSense Automation in Biopharmaceutical Product
Table 96. RheoSense Response to COVID-19 and Related Developments
Table 97. Eirechrom Business Overview
Table 98. Eirechrom Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Eirechrom Automation in Biopharmaceutical Product
Table 100. Eirechrom Response to COVID-19 and Related Developments
Table 101. BioProcess International Business Overview
Table 102. BioProcess International Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. BioProcess International Automation in Biopharmaceutical Product
Table 104. BioProcess International Response to COVID-19 and Related Developments
Table 105. Novasep Business Overview
Table 106. Novasep Automation in Biopharmaceutical Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Novasep Automation in Biopharmaceutical Product
Table 108. Novasep Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Automation in Biopharmaceutical Product Picture
Figure 2. Automation in Biopharmaceutical Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Automation in Biopharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Automation in Biopharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Automation in Biopharmaceutical Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Automation in Biopharmaceutical Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Automation in Biopharmaceutical Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Automation in Biopharmaceutical Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Automation in Biopharmaceutical Market Size Market Share, 2019-2021
Figure 1. Automation in Biopharmaceutical Product Picture
Figure 2. Automation in Biopharmaceutical Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Automation in Biopharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Automation in Biopharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Automation in Biopharmaceutical Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Automation in Biopharmaceutical Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Automation in Biopharmaceutical Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Automation in Biopharmaceutical Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Automation in Biopharmaceutical Market Size Market Share, 2019-2021
